Skip to content

Internet-delivered Cognitive Behavior Therapy for Atrial Fibrillation

Internet-delivered Cognitive Behavior Therapy for Atrial Fibrillation - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03378349
Enrollment
126
Registered
2017-12-19
Start date
2018-01-08
Completion date
2020-09-20
Last updated
2020-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Atrial Fibrillation

Brief summary

The aim is to evaluate if internet- delivered cognitive behavior therapy (CBT), based on exposure principles and behavioral activation, improves QoL and symptom burden in patients with symptomatic atrial fibrillation (AF) compared to treatment as usual. The study will include 120 patients with symptomatic AF despite optimal medical treatment in accordance with current guidelines.

Detailed description

Atrial fibrillation (AF) is the most common cardiac arrhythmia (irregular heartbeat) affecting 3% of the population. AF is associated with poor quality of life (QoL) and large costs for society. In a considerable proportion of patients, AF symptoms (e.g., palpitations, fatigue, and chest pain) are not alleviated by current medical or interventional treatments. Psychological factors can worsen AF symptoms, and anxiety and depression are common among AF patients. Symptom preoccupation and avoidance of social and physical activities are likely to play important roles in the development of anxiety, depression, disability and healthcare utilization. The aim is to evaluate if CBT, based on behavioral activation and exposure principles, improves wellbeing and QoL in symptomatic AF patients more than a wait list offered treatment as usual. Method: A randomized controlled trial. Participants are randomized to internet-delivered CBT for 10 weeks (N=60) or to treatment as usual (N=60). The internet-delivered CBT-program will last for 10 weeks and include weekly therapist support, consisting of online messages and telephone calls. Patients on the treatment as usual wait list will be provided standardized written information about basic self-management in AF. The treatment as usual wait list will be crossed over to treatment 3 months after the treatment group has completed treatment.

Interventions

The intervention lasts for 10 weeks and include: Education, Interoceptive exposure, exposure in-vivo, combining in-vivo exposure with interoceptive exposure, behavioral activation and relapse prevention. Include the guidance of a minimum weekly contact with a CBT psychologist.

BEHAVIORALTreatment as usual

Consist of standardized AF information that emphasizes that an active physical and social lifestyle is necessary to maintain good health, without the guidance of a psychologist or any CBT interventions.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria: A) Paroxysmal AF ≥ once per month that causes moderate to severe symptoms and leads to significant distress or interferes with daily life (i.e. EHRA class ≥ IIb) ; B) Age 18-75 years; C) On optimal medical treatment; D). Able to read and write in Swedish.

Exclusion criteria

* (E) heart failure with severe systolic dysfunction (ejection fraction ≤ 35%); (F) significant valvular disease; (G) planned ablation for AF or ablation within 3 months before assessment; (H) other severe medical illness; (I) any medical restriction to physical exercise; (J) severe psychiatric disorder, severe depression, or risk of suicide; (K) alcohol dependency.

Design outcomes

Primary

MeasureTime frameDescription
The Atrial Fibrillation Quality of Life (AFEQT)From baseline to 6 months PRIMARY ENDPOINTThe AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.

Secondary

MeasureTime frameDescription
Cardiac Anxiety Questionary (CAQ)From baseline to 12 weeksSymptom preoccupation
WHODAS 2.0 (12-item version)From baseline to 6 monthsGeneral quality of life
Symptom checklist Severity and Frequency Scale (SCL)From baseline to 12 weeksAF related symptoms
Atrial Fibrillation Severity ScaleFrom baseline to 12 weeksSymptomatic burden
Patient Health Questionnaire (PHQ-9)From baseline to 12 weeksDepression
PHQ-9From baseline to 6 monthsDepression
Client satisfaction QuestionnaireFrom baseline to 12 weeksTreatment satisfaction
Adverse eventsFrom baseline to 12 weeksPotential adverse reactions to the treatment
Electrocardiography (ECG) measurementFrom baseline to 12 weeksChange in symptomatic burden. The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic non-AF episodes)
ECG measurementFrom baseline to 6 monthsChange in symptomatic burden. The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic non-AF episodes)
the World Health Organization Disability Assessment Schedule (WHODAS 2.0, 12- item version)From baseline to 12 weeksGeneral quality of life

Other

MeasureTime frameDescription
Healthcare consumption and work loss:Tic-PFrom baseline to 12 weeksThe Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry assesses societal cost during the last month. These costs include the participant's health care consumption (direct medical costs), time spent in other health promoting activities (direct non-medical costs), and sick leave, unemployment, and reduced work capacity at work and in the domestic realm (indirect non-medical costs).
AccelerometerFrom baseline to 12 weeksObjective measurement of physical activity 1 week
The International Physical Activity QuestionnaireFrom baseline to 6 monthsPhysical activity
Body Sensation QuestionnaireFrom baseline to 12 weeksFear of bodily sensations
Anxiety Sensitivity IndexFrom baseline to 12 weeksAnxiety sensitivity
Perceived stress scale (4-item version)From baseline to 12 weeksStress reactivity
Self-rated health, 1 itemFrom baseline to 12 weeksThe measure consists of a single item that asks the participants to rate their overall health as excellent, good, fair, or poor.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026